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Background: Many patients with ST-segment elevation myocardial infarction (STEMI) have non-
culprit lesions (NCLs) in other coronary arteries, for which optimal management is uncertain. In the 
COMPLETE trial, percutaneo┌ゲ Iﾗヴﾗﾐ;ヴ┞ ｷﾐデWヴ┗Wﾐデｷﾗﾐ ふPCIぶ ﾗa WﾉｷｪｷHﾉW NCLゲ ふ┗WゲゲWﾉ Sｷ;ﾏWデWヴ дヲくヵﾏﾏぶ 
improved hard clinical outcomes, compared with conservative treatment. However, 99.3% of NCLs 
┘WヴW ;ゲゲWゲゲWS H┞ ┗ｷゲ┌;ﾉｷゲ;デｷﾗﾐ ﾗa デｴW ;ﾐｪｷﾗｪヴ;ﾏ ┌ゲｷﾐｪ ; デｴヴWゲｴﾗﾉS ﾗa дΑヰХ ゲデWﾐﾗゲｷゲが ┘ｴｷIｴ is an 
inaccurate method for assessing haemodynamic significance. A pressure wire was used to assess 
ヮｴ┞ゲｷﾗﾉﾗｪｷI;ﾉ ゲｷｪﾐｷaｷI;ﾐIW ふFFR гヰくΒヰぶ ｷﾐ ﾗﾐﾉ┞ ヰくΑХ ﾗa NCLゲ デｴ;デ ┗ｷゲ┌;ﾉﾉ┞ ｴ;S ヵヰ-69% stenosis.  
                 
Figure 1: (Left) Angiogram of right coronary artery in a patient with STEMI affecting the left coronary artery. There is a 
proximal bystander lesion in the right coronary artery (arrow). (Right) Using VIRTUheart the bystander lesion is modelled, 
and then computational fluid dynamics are used to compute the virtual FFR. 
Hypothesis: In the real-┘ﾗヴﾉSげが デｴW ヮヴﾗヮﾗヴデｷﾗﾐ ﾗa STEMI ヮ;デｷWﾐデゲ ┘ｷデｴ NCL ゲデWﾐﾗゲWゲ дヵヰХ デｴ;デ ;ヴW ﾗa 
physiological significance, based upon fractional flow reserve (FFR) estimation, is low.  
Methods: The angiograms of consecutive STEMI patients undergoing primary PCI were 
retrospectively reviewed by an interventional cardiologist to identify cases that either had NCL 
ゲデWﾐﾗゲWゲ ﾗa ヵヰ-ヶΓХ デｴ;デ ┘ﾗ┌ﾉS ｴ;┗W HWWﾐ WﾉｷｪｷHﾉW aﾗヴ COMPLETE ｷa FFR ┘;ゲ гヰくΒヰ ﾗヴ a┌lfilled the 
COMPLETE WﾉｷｪｷHｷﾉｷデ┞ IヴｷデWヴｷ; H┞ ┗ｷゲ┌;ﾉ ;ゲゲWゲゲﾏWﾐデ ふゲデWﾐﾗゲｷゲ дΑヰХぶく TｴW ┗ｷヴデ┌;ﾉ FFRゲ ﾗa NCLゲ ┘WヴW 
computed using the VIRTUheart tool. The primary outcome was the proportion of all real world 
STEMI ヮ;デｷWﾐデゲ ┘ｷデｴ NCL ゲデWﾐﾗゲWゲ дヵヰХく SWIﾗﾐS;ヴ┞ ﾗutcomes were a) the proportion of patients 
┘ｷデｴ NCL ゲデWﾐﾗゲWゲ ﾗa ヵヰ-ヶΓХ ┘ｴﾗ ｴ;S ┗FFR гヰくΒヰ ふけFFR-guided PCI group; b) the proportion of NCL 
stenoses of бΑヰ% with ; ┗ｷヴデ┌;ﾉ FFR гヰくΒヰ ふけPCI ┘ｷデｴﾗ┌デ FFRげ ｪヴﾗ┌ヮぶく 
Results: Aﾐｪｷﾗｪヴ;ﾏゲ aヴﾗﾏ ヲヴΒ ヮ;デｷWﾐデゲ ヮヴWゲWﾐデｷﾐg with STEMI and undergoing primary PCI were 
ヴW┗ｷW┘WSく Αヰ I;ゲWゲ ふヲΒХぶが were found with Βヶ NCLs that would have been potentially suitable for 
inclusion in COMPLETE ふΓヵХ CI: ヲヲくヴ% to 33.6%)く Oa デｴWゲW Αヰ I;ゲWゲが ヵΓХ of NCLs fell into the FFR-
ｪ┌ｷS;ﾐIWげ ふヵヰ-69% stenosis) group ;ﾐS ヴヱХ ｷﾐデﾗ デｴW けPCI ┘ｷデｴﾗ┌デ FFRげ ふдΑヰХ ゲデWﾐﾗゲｷゲぶ ｪヴﾗ┌ヮく Oa デｴW 
Αヰが ヴΓ angiograms ふΑヰХぶ ┘WヴW デWIｴﾐｷI;ﾉﾉ┞ ゲ┌ｷデ;HﾉW aﾗヴ ﾏﾗSWﾉﾉｷﾐｪく A ヮﾗゲｷデｷ┗W ┗FFR ┘;ゲ aﾗ┌ﾐS ｷﾐ ヴΑХ ﾗa 





Haemodynamic significance of NCLs  Total no. 
(%) 
vFFR ≤0.8 (%) vFFR >0.8 (%) 
FFR-guidance for PCI 10 (32) 21 (68) 31 (63) 
PCI without FFR 13 (72) 5 (28) 18 (37) 
Total (%) 23 (47) 26 (53) 49 (100) 
Table 1: Breakdown of haemodynamic significance (vFFR ≤0.8) for NCLs successfully modelled using 




Cohort no. (%) 
COMPLETE Sheffield 
FFR-guidance for PCI 37 (0.7) 51 (59.3) 
PCI without FFR 5151 (99.3) 35 (40.7) 
Total 5188 (100) 86 (100) 
Table 2: Number of lesions suitable for pressure wire in COMPLETE and Sheffield populations 
 
Conclusion: In a real-┘ﾗヴﾉSげ STEMI ヮﾗヮ┌ﾉ;デｷﾗﾐが ヲΒХ ﾗa ヮ;デｷWﾐデゲ Iﾗ┌ﾉS HW IﾗﾐゲｷSWヴWS aﾗヴ WｷデｴWヴ FFR 
;ゲゲWゲゲﾏWﾐデ ふNCL ゲデWﾐﾗゲｷゲ ヵヰ-69%) or PCI without FFR according to the COMPLETE study criteria. 
Hﾗ┘W┗Wヴが ﾗa デｴﾗゲWが ﾐW;ヴﾉ┞ ヶヰХ ゲｴﾗ┌ﾉS ┌ﾐSWヴｪﾗ ヮｴ┞ゲｷﾗﾉﾗｪｷI;ﾉ ;ゲゲWゲゲﾏWﾐデが ;IIording to COMPLETE 
WﾉｷｪｷHｷﾉｷデ┞ IヴｷデWヴｷ;が W┗Wﾐ デｴﾗ┌ｪｴ ┗Wヴ┞ aW┘ ┘WヴW ;Iデ┌;ﾉﾉ┞ WﾐヴﾗﾉﾉWS ﾗﾐ デｴｷゲ H;ゲｷゲく Oa デｴW ヶヰХが ﾗﾐﾉ┞ ンヲХ 
┘WヴW ヮｴ┞ゲｷﾗﾉﾗｪｷI;ﾉﾉ┞ ゲｷｪﾐｷaｷI;ﾐデき ;ﾐSが ﾗa ;ﾉﾉ デｴW NCLゲが ﾗﾐﾉ┞ ヴΑХ ┘WヴW ヮｴ┞ゲｷﾗﾉﾗｪｷI;ﾉﾉ┞ ゲｷｪﾐｷaｷI;ﾐデく 
Further work is required to determine whether virtual FFR might provide a cost-effective means of 
identifying patients who will benefit from NCL revascularisation.   
 
